
What We're Reading: Nonprofit Hospitals' Charity Care; FDA Approves New LDL-C Drug; Emergency Coronavirus Funding
Nonprofit hospitals with the highest net income were shown in a study to devote the smallest proportion of earnings to charity care; FDA approves a novel drug to lower low-density lipoprotein cholesterol (LDL-C); the White House is seeking emergency funding from Congress to fight the novel coronavirus.
Wealthiest Nonprofit Hospitals Devote Lowest Proportion to Charity Care
According to a study published last week in
FDA Approves New Type of Cholesterol-Lowering Drug
Last Friday, the FDA approved Esperion Therapeutics Inc’s low-density lipoprotein cholesterol—lowering drug bempedoic acid (Nexletol), a new type of drug that aims to expand therapeutic efficacy for patients who cannot tolerate or do not get enough benefit from widely used statin pills such as atorvastatin (Lipitor) and rosuvastatin (Crestor), according to
White House Seeks Emergency Coronavirus Funding
According to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.